Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-15T10:07:03.515Z Has data issue: false hasContentIssue false

Adopting new medical technologies in Russian hospitals: what causes inefficiency? (qualitative study)

Published online by Cambridge University Press:  02 March 2017

Sergey Shishkin*
Affiliation:
Director, Center for Health Policy, National Research University Higher School of Economics, Moscow, Russia
Liudmila Zasimova
Affiliation:
Associate Professor, Faculty of Economics, National Research University Higher School of Economics, Moscow, Russia
*
*Correspondence to: Dr Sc. Sergey Shishkin, 20 Myasnitskaya Ulitsa, Office 221, Moscow, 101000, Russia. Email: shishkin@hse.ru
Rights & Permissions [Opens in a new window]

Abstract

The adoption of new medical technologies often generates losses in efficiency associated with the excess or insufficient acquisition of new equipment, an inappropriate choice (in terms of economic and clinical parameters) of medical equipment, and its poor use. Russia is a good example for exploring the problem of the ineffective adoption of new medical technologies due to the massive public investment in new equipment for medical institutions in 2006–2013. This study examines the procurement of new technologies in Russian hospitals to find the main causes of inefficiency. The research strategy was based on in-depth semistructured interviews with representatives of prominent actors (regional health care authorities, hospital executives, senior physicians). The main result is that inefficiencies arise from the contradiction between hospitals’ and authorities’ motivation for acquiring new technologies: hospitals tend to adopt technologies which bring benefits to their department heads and physicians and minimize maintenance and servicing costs, while the authorities’ main concern is the initial cost of the technology.

Information

Type
Articles
Copyright
© Cambridge University Press 2017 
Figure 0

Table 1Use of medical technology units in Russia and Organization for Economic Co-operation and Development (OECD) countries

Figure 1

Table 2Financial sources to reimburse medical treatment and technology adoption

Supplementary material: File

Shishkin and Zasimova supplementary material

Shishkin and Zasimova supplementary material 1

Download Shishkin and Zasimova supplementary material(File)
File 14.1 KB